Drug properties affecting aerosol behavior

Respiratory Care

Volumn 45, Issue 6, 2000, Pages 652-666

  Suarez, Sandra ^a   Hickey, Anthony J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Aerosol; Drug interaction; Impaction; Pulmonary clearance; Pulmonary deposition; Sedimentation

Indexed keywords

RESPIRATORY TRACT AGENT;

AEROSOL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRY POWDER; HUMAN; METERED DOSE INHALER; NEBULIZER; PHARMACODYNAMICS;

ABSORPTION; AEROSOL PROPELLANTS; AEROSOLS; BIOLOGICAL TRANSPORT; DRUG INTERACTIONS; HUMANS; LUNG; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; RESPIRATORY MECHANICS; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES;

EID: 0033931658     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (160)

1. Neville A, Palmer JB, Gaddie J, May CS, Palmer KN, Murchison LF. Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. Br Med J 1977:1(6058):413-414.
2. Newman S, Clarke S Aerosols in medicine: principles, diagnosis and therapy. In. Moren F, Newhouse M, Dolovich, M. editors Aerosol in therapy Amsterdam: Elsevier; 1985.
3. Clark TJ Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet 1972;1(7765):1361-1364.
4. Clarke SW, Newman SP. Therapeutic aerosols, 2 Drugs available by the inhaled route. Thorax 1984;39(1):1-7.
5. Lourenco R, Cotromanes E, Clinical aerosols II. Therapeutic aerosols. Arch Int Med 1982,142(13):2299-2308
6. Byron PR, Patton JS Drug delivery via the respiratory tract. J Aerosol Med 1994.70(1):49-75.
7. Patton J, Platz R. Routes, of delivery: case studies pulmonary delivery of peptides and proteins for systemic action Adv Drug Deliv Rev 1992.8:179-196.
8. Hickey AJ, Martonen TB. Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives. Pharm Res 1993:10(1) 1-7
9. Schlesinger RB. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J Toxicol Environ Health 1985;15(2).197-214.
10. Atkins P, Clark AR Drug delivery to the respiratory tract and drug dosimetry. J Aerosol Med 1994;7(1):33-38.
11. Lippmann M, Schlesinger RB. Interspecies comparisons of particle deposition and mucociliary clearance in tracheobronchial airways. J Toxicol Environ Health 1984.13(2-3):441-469.
12. Byron PR. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J Pharm Sci 1986: 75(5):433-438
13. Anderson M, Philipson K, Svartengren M, Camner P. Human deposition and clearance of 6-um panicles inhaled with an extremely low flow rate. Exp Lung Res 1995:21(1):187-195.
14. Stahlhofen W, Rudolf G, James A. Intercomparison of experimental regional aerosol deposition data. J Aerosol Med 1989:2.285-308.
15. Svanengren K, Phihpson K, Svartengren M, Anderson M, Camner P. Tracheobronchial deposition and clearance in small airways in asthmatic subjects Eur Respir J 1996;9(6):1123-1129.
16. Barnes PJ, Basbaum CB, Nadel JA. Autoradiographic localization of autonomic receptors in airway smooth muscle: marked differences between large and small airways. Am Rev Respir Dis 1983.127(6): 758-762.
17. Brown RA Jr. Schanker LS Absorption of aerosolized drugs from the rat lung. Drug Metab Dispos 1983:11(4):355-360
18. Effros RM, Mason GR. Measurements of pulmonary epithelial permeability in vivo. Am Rev Respir Dis 1983:127(5 Pt 2):S59-S65
19. Enna S, Schanker LS. Absorption of saccharides and urea from the rat lung. Am J Physiol 1972;222(2):409-414.
20. Burton JA, Schanker LS. Absorption of antibiotics from the rat lung Proc Soc Exp Biol Med 1974.145(3):752-756.
21. Byron P, Phillips E, Absorption, clearance and dissolution on the lung respiratory drug delivery. Boca Raton FL: CRC. 1990: 107-141.
22. Johnson, M Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. Allergy Clin Immunol 1996:97(1 Pt 2). 169-177.
23. Gonda I. Drugs administered directly into the respiratory tract: modeling of the duration of effective drug levels. J Pharm Sci 1988; 77(4): 340-346.
24. Suarez S. Gonzalez-Rothi RJ, Schreier H, Hochhaus G Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm Res 1998:15(3):461-165.
25. Dolovich M Lung dosc, distribution, and clinical response to therapeutic aerosols. Aerosol Sci Tech 1993;18:230-240.
26. Schultz R, Miller N, Christensen J. Method for evaluation of suspension characteristics relevant to metered dose inhaler formulations. Pharm Res 1990:7 s-88
27. Konig P Spacer devices used with metered-dose inhalers: breakthrough or gimmick? Chest 1985.88(2):276-284.
28. Sciarea JJ. Cutte A. Simulated respiratory system for in vitro evaluation of two inhalation delivery systems using selected steroids. J Pharm Sci 1978;67(10):1428-1431.
29. Dolovich J New delivery systems and propellants. Can Respir J 1999:6(3).290-295.
30. Hickey A. Inhalation therapy. Drug Topics 1989;133:60-69.
31. Gonda I. Therapeutic aerosols. In: Aulton M, editor. Pharmaceutics: the science of dosage form design. Edingburgh: Churchill Livingstone, 1988: 341.
32. Epstein SW, Manning CP, Ashley MJ, Corey PN. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J 1979; 120(7):813-816
33. Dolovich M, Ruffin RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered dose inhalers. Chest 1981,80(6 Suppl): 911-915.
34. Gupta P, Hickey A. Contemporary approaches in aerosolized drug delivery to the lung. J Control Rel 1991;17:129-148.
35. Dolovich M. Rationale for spacer use in children. Pediatr Pulmonol Suppl 1997;16:184-185.
36. Newman SP, Moren F, Pavia D, Little F, Clarke SW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981;124(3).317-320.
37. Byron P. R Jashnani, Germin S. Efficiency of aerosolization from dry powder blends of terbutaline sulphate and lactose NF with different particle size distribution. Pharm Res 1990:7.81s.
38. Malem H, Ward M, Henry D, Smith WH, Gonda I. Early experience with a vertical spinning disc nebuliser Lancet 1981:2(8248):644-646.
39. Brown K The formulation and evaluation of powders for inhalation, in: Ganderton D, Jones, T, editors. Drug delivery to the respiratory tract. England: VCH and Ellis Horwood Ltd; 1987: 119-123.
40. Ferron G. The size of soluble aerosol particles as a function of the humidity of the air. Application to the human respiratory tract. J Aerosol Sci 1977.8:251-267.
41. Mercer T Properties of aerosols. In: Mercer T. editor. Aerosol technology in hazard evaluation. Neu York: Academic Press, 1973
42. Phipps P, Borham P, Gonda I, Bailey D, Bautovich G, Anderson S. A rapid method for evaluation of diagnostic radioaerosol delivery systems. Eur J Nucl Med 1987:13(4) 183-186.
43. Lewis R Therapeutic aerosols. In: Cumming G, Bonsignore G, editors. Drugs and the lungs. Vol 63. New York: Plenum Press, 1984.
44. Schlesinger RB. Clearance from the respiratory tract Fundam Appl Toxicol 1985.5(3):435-450
45. Anderson PJ, Wilson JD, Hillei FC, Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest 1990:97(5):1115-1120.
46. Carpenter RL. Aerosol deposition modeling using ACSL. Drug Chem TOK 1999:22(1):73-90.
47. O'Doherty MJ, Miller RF. Aerosols for therapy and diagnosis. Eur J Nucl Med 1993:20(12).201-1213.
48. Yu J, Chien YW Pulmonary drug delivery, physiologic and mechanistic aspects. Crit Rev Ther Drug Carrier Syst 1997:14(4).395-453.
49. Brain JD, Valberg PA Deposition of aerosols m the respiratory tract (review). Am Rev Respir Dis 1979:120(6):1325-1373
50. Lippmann M. Regional deposition of particles in the human respiratory tract handbook of physiology American Physioligical Society: 1977.
51. Zainudin BM. Therapeutic aerosol, principles and practices. Med J Malaysia 1993.48(3).259-268.
52. Byron P Some future perspectives for unit dose inhalation aerosols. Drug Dev Ind Pharm 1976:12 993-1015.
53. Byron P. Pulmonary targeting with aerosols. Pharm Tech 1987.11: 42-56.
54. Bailey M, Kreyling W, Andre S, Batchelor A, Colhecr C. Drosselmeyer E, et al. An interspecies comparison of the lung clearance of inhaled mododisperse cobalt oxide particles. Part 1: objectives and summary of results. J Aerosol Sci 1989:20.169-188.
55. Cuddihy R. Respiratory tract retention of inhaled particles it experimental animals. Inhalation Toxicology Research Institute Annual Report 1976:137-142.
56. Cuddihy R. Mathematical models for predicting clearance of inhaled radioactive substances. Lung Model Inhal Radioactive Mater 1984: 167-179.
57. Hakkinen AM, Uusi-Heikkila H, Jarvinen M, Saali K, Karhumaki L. The effect of breathing frequency on deposition of drug aerosol using an inhalation-synchronized dosimeter in healthy adults. Clin Physiol 1999;19(3):269-274.
58. Gonda I. Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract. Crit Rev Ther Drug Carrier Syst 1990:6(4): 273-313.
59. Valberg PA, Brain JD, Sneddon SL, Le Mott SR. Breathing patterns influence aerosol deposition sites in excised dog lungs J Appl Physiol 1982;53(4):824-837.
60. Mygind N. Structure and function of the respiratory tract in: Moren F. Newhouse M. editors. Aerosols in medicine New York: Elsevier: 1985.
61. Wiebel E. The lung: scientific foundations. New York: Raven Press: 1991.
62. Mercer RR, Russell ML, Roggli VL, Crapo JD. Cell number and distribution in human and rat airways. Am J Respir Cell Mol Biol 1994:10(6):613-624.
63. Weibel E Morphometries of the lung Handbook of physiology. Vol 1. Washington DC: American Physiological Society; 1964: 285.
64. Batenburg JJ Surfactant phospholipids. synthesis and storage. Am J Physiol 1992:262(4 Pt 1)L367-L385.
65. Hawgood S. Pulmonary surfactant apoproteins: a review of protein and gemimic structure. Am J Physiol 1989:257(2 Pt 1):L13-L22.
66. Miyamura K, Malhotra R, Hoppe HJ, Reid K. Phizackerley P. Macpherson P, Lopez-Bernal A Surfactant proteins A (SP-A) and D ISP-D: levels in human amniotic fluid and localization in the fetal membranes. Biochim Biophys Acta 1994;1210(3):303-303.
67. van Iwaarden F, Welmers B, Verhoef J, Haagsman HP. van Golde LM. Pulmonary surf jetant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990.2(1):91-98
68. Evander E, Wollmer P, Jonson B, Lachmann B. Pulmonary clearance of inhaled 99mTc-DTPA: effects of surfactant depiction by lung lavage. J Appl Physiol 1987.62(4):1611-1614
69. Wollmer P, Evander E, Jonson B. Pulmonary clearance of inhaled 99m Tc-DTPA. effect of surfactant depletion in rabbits. Clin Physiol 1986.6(1) 85-89
70. Sanderson MJ, Sleigh MA Ciliary activity of cultured rabbit tracheal epithelium: beat pattern and metachrony. J Cell Sci 1981;47:331-347
71. Lucas A, Douglas L. Principles underlying ciliary activity in the respiratory tract Arch Otolaryngol 1934:34.495.
72. Jeftrey PK. The origins of secretions in the lower respiratory true. Eur J Respir Dis Suppl 1987.153 34-42.
73. Rogers DF, Dewar A. Neutral control of airway mucus secretion. Biomed Pharmacother 1990.44(9).447-153.
74. Richardson PS, Pealfield AC. The control of airway mucus secretion. Eur J Respir Dis Suppl 1987.153 43-51
75. Sturgess J. Reid L An organ culture study of the effect of drugs on the secretory activity of the human bronchial submucosal gland Clin Sci 1972.43(4):533-543.
76. Svartengren K. Ericsson CH. Svartengren M. Mossberg B. Philipson K, Carmer P. Deposition and clearance in large and small airways in chronic bronchitis Exp Lung Res 1946.22(5) 555-576
77. Scherer PWI Mucus transport by cough Chest 1981:80(6 Suppl): 833-383.
78. Oberdorster G. Lung clearance of inhaled insoluble and soluble particles. J. Aerosol Med 1988; 1:289-330.
79. Devereux TR, Domin BA, Philpot RM Xenobiotic metabolism by isolated pulmonan cells Pharmacol Ther 1989.41(1-2)243-256.
80. Bend JR; Serabjit-Singh CJ, Philpot RM The pulmonan uptake. accumulation and metabolism of xenobiotics. Annu Rev Pharmacol Toxicol 1985;25:97-125
81. Foster WM, Langenhack E Bergofsky E Measurement of tracheal and bronchial mucus velocities in man relation to lung clearance. J Appl Physiol 1980:48(6) 965-971
82. Kimoto A, Saitou M, Hirano Y, Iwat T, Tomioka K, Miyata K, Yamada T. A new, simple method for measuring mucociliary clearance in guinea pigs Pulm Pharmacol Thera 1999:12(1)49-54.
83. Patrick G, Stirling C. Measurement of mucociliary clearance from the trachea of conscious and anesthetized rats J Appl Physiol 1977: 42(3):451-455.
84. Svanengren M. Widtskiold-Olsson K, Philipson K, Camner P. Retention of particles on the first bifurcation and the trachea of rabbits. Bull Physiopathol Respir 1981.17(1):87-91.
85. Bailey MR, Fry FA, James AC. The long-term clearance kinetics of insoluble particles from the human lung Ann Occup Hyg 1992; 26(1-4):273-290.
86. Falk R, Philipson K, Svartengren M. Jarvis N. Bailey M, Camner P. Clearance of panicles from small ciliated airways Exp Lung Res 1997;23(6):495-515.
87. Lafortuna CL, Fazio F. Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis. Respiration 1984,45(2):111-123.
88. Fazio F. Lafortuna CL. Beclomethasone dipropionate does not affect mucociliary clearance in patients with chronic obstructive lung disease Respiration 1986.50(1):62-65.
89. Foster WM. Langenhack EG, Bergofsky EH. Disassociation in the mucociliary function of central an peripheral airways of asymptomatic smokers Am Rev Respir Dis 1985:132(3):633-639
90. Messma MS. O'Riordan TG. Smaldone GC. Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis 1991,143(5 Pt 1):993-997.
91. Svartengien M. Ericsson CH. Philpson K, Mossberg B. Camner P. Tracheobronchial clearance in asthma-discordant monozygotic twins Respiration 1989:56(1-2):70-79.
92. Brain JD Mechanisms, measurement, and significance of lung macrophage function. Environ Health Perspect 1992:97:5-10.
93. Stone KC. Mercer RR. Gehr P. Stockstill B. Crapo JD. Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 1992:6(2):235-243.
94. Gehr P, Gerser M. Im Hof V. Schuren S, Waber U. Baumann M. Surfactant and inhaled particles in the conducting airways: structural, stereological, and biophysical aspects. Microsc Res Technol 1993.26(6) 423-436.
95. Beck BD. Brain JD. Bohannon DE. An in vivo hamster bioassay to assess the lovicity of particulates for the lungs. Toxicol Appl Pharmacol 1982;66(1).9-29.
96. Lalot C. Atkins K. Concessio N. Pettis R, Hickey A. Lung deposition and alveolar macrophage uptake of microparticles from suspension aerosols in guinea pigs. Society of Toxicology. 35th Annual Meeting, Anaheim, CA: 1996.
97. Oberdorster G. Fenn J. Gelein R, Soderholm SC. Finkelstein J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles Environ Health Perspect 1992:97:193-199.
98. Snipes MB, Clem MF. Retention of microspheres in the rat lung after intratracheal instillation. Environ Res 1981:24(1):33-41.
99. Oberdorster O. Cox C. Gelein R. Intratracheal instillation versus intratracheal inhalation of tracer particles for measuring lung clearance function Exp Lung Res 1997:23(1): 17-34.
100. Ferin J Pulmonary retention and clearance of particles. Toxicol Lett 1994.72(1-3):121-125.
101. Green GM, Jakab GJ. Low RB, Davids GS. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 1977:115(3):479-514
102. Kreyling W. Ferron G, Schumann G. Heilmann P. Macrophage mediated particle transport form the lungs. J Aerosol Med 1990:3: 285
103. Snipes MB. Boeker BB. McClellan RO. Retention of monodisperse onpolydisperse aluminosilicate particles inhaled by dogs, rats and mice. Toxicol Appl Pharmacol 1983,69(3):345-362.
104. Bowden DH. Macrophages, dust, and pulmonary diseases. Exp Lung Res 1987,12(2):89-107.
105. Snipes MB, Chavez GT, Muggenberg BA. Disposition of 3-,7- and 13-microns microspheres instilled into lungs of dogs. Environ Res 1984;33(2):333-342.
106. Ferin J. Oberdorster G. Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol 1992: 6(50:535-542.
107. Ferin J. Oberdorster G. Sebring R. Lehnen B. Are particles cleared from the pulmonary interstitium via the airways? J Aerosol Med 1992:5:286.
108. Shepherd VL. The role of the respiratory burst of phagocytes in host defense. Semm Respir Infect 1986:1(2).99-106
109. Sugar AM. Field KG. Characterisation of murine bronchoalveolar macrophage respiratory burst: comparison of soluble and particulate stimuli J Leuko Biol 1988:44(6):500-507.
110. Patton J. Mechanisms of macromolecule absorption by the lungs. Adv Drug Del Rev 1996:19.3-36.
111. Giver RE. Schneeberger EE. Walters DV. Epithelial solute permeability, ion transport and tight junction morphology in the developing lung of the feul lamb. J Physiol (Lond) 1981:315:395-412.
112. Schanker LS. Drug absorption from the lung. Biochem Pharmacol 1978:27(4):381-385.
113. Gardiner T, Schanker L. Absorption of disodium cromoglycate form the rat lung: evidence of carrier transport. Xenobiotica 1974:4:725-731.
114. Goodman BE, Wangensteen D. Alveolar epithelium permeability to small solutes: developmental changes J Appl Physiol 1982:52(1): 3-8.
115. Kim K. Matsukama Y. Lee V. Crandall E. Characteristics of albumin absorption across rat alveolar epithelial cell monolayers (abstract). FASEB J 1995:9:A569
116. Kim KJ. Crandall ED. Heteropore populations of bullfrog alveolar epithelium. J Appl Physiol 1983:54(1): 140-146.
117. Chandra T, Miller IF, Yeates DB. A pore transport model for pulmonary alveolar epithelium Ann Biomed Eng 1992;20(4).481-494
118. Mostov KE. Simister NE. Transcytosis. Science 1985:43(2 Pt 1): 389-390.
119. Gil J. Number and distribution of plasmalemmal vesicles in the lung. Fed Proc 1983:42(9) 2414-2418
120. Gonzales-Crussi FW. Boston R The absorptive function of the neonatal lung: ultrastructural study of horseradish peroxidase uptake at the onset of ventilation Lab Invest 1972:2611(1):114-121.
121. Kim K. Rattan V. Oh P. Schnitzer J. Kalra V. Crandall E Specific albumin-binding protein in alveolar epithelial cel monolayers (abstract). Am J Respir Crit Care Med 1995:151(4 Pt 2) A190
122. Schmuer J, Oh P. Albondin-mediated capillary permeability to albumin: differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. J Biol Chem 1994:269 A6072-A6082.
123. Lisanti MP, Scherer PE. Vidugiriene J. Tang Z. Hermanowski-Vosatka A. Tu YH. et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994:1260(1):111-126.
124. Smith P, Yeulet S. Cuerone D, Drake F. Cook M. Wall D. Marcello J SK&F 110679: comparison of absorption following oral or respiratory administration. J Control Rel 1994:28 67-77
125. Barrels H. Gestern HJ. Voss-Wermbter G Communicating-occluding junction complexes in the alveolar epithelium: a freeze-fracture study. Am Rev Respir Dis 1980:121(6).1017-1024.
126. Schneegerger EE. Structure of intercellular junctions in different segments of the intrapulmonary vasculature. Ann NY Acad Sci 1982:54:63.
127. Reed CJ. Lock EA. DeMatteis F. NADPH: cytochrome P-450 reductase in olfactory epithelium: relevance to cytochrome P-450-dependent reactions. Biochem J 1986:240(2):585-592.
128. Bundgaard M. The three-dimensional organization of tight junctions in a capillary endothelium revealed by serial-section electron microscopy. J Ultrastruct Res 1984:88(1):1-17.
129. Schneeberger E. Karnovsky M Substructure of intercellular junctions in freeze-fractured alveolar-capillary membranes of mouse lung. Circ Res 1976:38(5):405-411.
130. Effros RM. Solute transport following aerosol deposition in the lungs In. Hickey J. editor. Inhalation aerosols: physical and biological basis for therapy Vol 94 New, York. Marcel Dekker: 1996: 139-154.
131. Normand IC. Oliver RE. Reynolds ED. Strang LB. Permeability of lung capillaries and alveoli to non-electrolytes in the foetal lamb J Physiol (Lond) 1971;219(2) 303-330.
132. Enna SJ. Schanker LS. Absorption of drugs from the rat lung. Am J Physiol 1972:223(5):1227-1231.
133. Lanman RC. Gillilan RM, Schanker LS Absorption of cardiac glycosides from the rat respiratory tract. J Pharmacol Exp Ther 1973:187(1): 105-111.
134. Adjei L. Gupta P. Inhalation delivery of therapeutic peptides and proteins In: Lenfant C. editor. Lung biology in health and disease. Vol 107 New York: Marcel Dekker: 1997: 1-913.
135. Nielson DW. Goerke J. Clements JA Alveolar subphase pH in the lungs of anesthetized rabbits. Proc Natl Acad Sci USA 1981,78(11): 7119-7123.
136. Effros RM, Mason G, Silverman P, Role of perfusion and diffusion in 14CO2 exchange in the rabbit lung. J Appl Physiol 1981;51(5): 1136-1144.
137. Effros RM., Mason GR, Reid E. Graham L. Silverman P. Diffusion of labeled water and lipophylic solutes m the lung. Microvasc Res 1985:29(1).45-55.
138. Okumura K. Iwakawa S. Yoshida T, Seki T, Komada F Intratracheal delivery of insulin: absorption from solution und aerosol by rat lung. Int J Pharm 1992;88:63-73.
139. Schanker LS. Mitchell EW. Brown RA Jr Species comparison of drug absorption from the lung after inhalation or intratracheal injection. Drug Metab Dispos 1986;14(1):79-88.
140. Effros RM Osmotic extraction of hypotonie fluid from the lungs J Clin invest 1974:54(4) 935-947
141. Effros R, Mason GR, Sietsema K. Hukkanen J, Silverman P. Pulmonary epithelial sieving of small solutes in rat lungs. J Appl Physiol 1988:65(2):640-648.
142. Yyping L, Mitra A Effects of formulation variables on the pulmonary delivery of insulin. Drug Dev Ind Pharm 1994;20 2017-2024.
143. Suarez S. Biopharmaceutical aspects relevant to pulmonary targeting of inhaled glucocorticords; application to liposomes and dry powders. Department of Pharmaceutics. University of Florida. Gainesville; 1997: 72-106.
144. Suarez S. O'Hara P. Hickey A. Uptake and disposition of rhodamine-labeled rifampicin-loaded poly(lactide-co-glycolide) microspheres following powder insufflation. Pharm Res 1998.1:S208.
145. Taylor KM, Taylor G, Kellaway IW. Stevens J. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm Res 1989:6(7):633-636.
146. Fielding RM, Abra RM. Factors affecting the release rate of terbutaline from liposome formulations after intratracheal instillation in the guinea pig. Pharm Res 1992;9(2):220-223.
147. Meibohm B, Hochhaus G, Moellmann H, Barth J, Derendorf H. Absorption profile of inhaled corticosteroids. Pharm Res 1997.14:5141.
148. Witschi HP, Hakkinen PJ. The role of toxicological interactions in lung injury (review). Environ Health Perspect 1984.55:139-148.
149. Amdurm M, Underhill D. The effects of various aerosols on the response of guinea pigs to sulfur dioxide. Arch Envirom Health 1968;16:462-468.
150. Kilburn KH. Particles causing lung disease. Environ Health Perspect 1984.55:97-100.
151. Curti P, Genghim M. Role of surfactant in alveolar defense against inhaled particles Respiration 1989:1:60.
152. Gaddum J. Hebb C. Silver A. Swan A. 5-Hydroxytryptamine: pharmacological action und destruction in perfused lungs. Q J Exp Physiol 1953.38:255-262.
153. Bakhle YS. Youdim MB The metabolism of 5-hydroxytryptamine und beta-phenylethylamme in perfused rat lung and in vitro. Br J Pharmacol 1979;65:147-154
154. Alabaster V. Inactivation of endogenous amines in the lungs. In: Bakhl. Y. Vane J. editors. Metabolic functions of the lung. Vol 3. New York Marcel Dekker. 1977 31
155. Edsbacker S. Jendbro M Modes to achieve topical selectivity of inhaled glucocorticosteroids-locus on budesonide In: Dalby R. Byton P. editors Respiratory drug delivery VI Hilton Head SC: Interphat Press: 1998 71-82
156. Mebn C Non-specific esterase in the alveolar tissues of hamster lung an electron microscope study Acta Anat (Basel) 1980:108(2): 184-192
157. Andersson P, Ryrfeldt A. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha.21-dipriopionate in human liver and lung homogenate. J Pharm Pharmacol 1984,36(11) 763-765
158. 2 agonists in acute asthma. Eur J Respir Dis Suppl 1982;122:126-131
159. 2-adrenoreceptor gene expression in human lung (abstract). Am Rev Respir Dis 1992.145(4 Pt 2) A834.
160. Peters MJ, Adcock IM. Brown CR, Barnes PJ Beta agonist inhibition of steroid-receptor DNA binding activity in human lung (abstract). Am Rev Respir Dis 1993;147(4 Pt 2):A772.